TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18657671

Group type: EXPERIMENTAL
Intervention: Sotalol (S) 167 ± 66 mg/d
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Beta-blockers (BB) 62 ± 26 mg/d for atenolol and 104 ± 47 mg/d for metoprolol
Number of subjects: 135

Group type: COMPARATOR
Intervention: Both Sotalol and Beta-blockers
Number of subjects: 135
Study: 15668282

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoendocrine therapy (2MT or 3MT)
Number of subjects: 309

Group type: COMPARATOR
Intervention: Adjuvant treatment (8 cycles of mitoxantrone, methotrexate with tamoxifen)
Number of subjects: 309
Study: 14511555

Group type: EXPERIMENTAL
Intervention: Atovaquone-proguanil (AP)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (mefloquine-artesunate)
Number of subjects: 39
Study: 12362076

Group type: EXPERIMENTAL
Intervention: New reference plane for HRT defined by OCT measurements
Number of subjects: 50
Study: 9989680

Group type: EXPERIMENTAL
Intervention: Energy-restricted diet with conventional foods (group A)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Energy-restricted diet with meal replacements (group B)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Both groups during phase 2
Number of subjects: 100
Study: 7780274

Group type: EXPERIMENTAL
Intervention: Conventional perimetry
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: White-noise field campimetry
Number of subjects: 368
Study: 2082307

Group type: EXPERIMENTAL
Intervention: Ketorolac 10 mg
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Ketorolac 30 mg
Number of subjects: 122

Group type: COMPARATOR
Intervention: Morphine 2 mg
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Morphine 4 mg
Number of subjects: 122
Study: 7369170

Group type: COMPARATOR
Intervention: 8 mg/kg caffeine
Number of subjects: 8

Group type: COMPARATOR
Intervention: 4 mg/kg coffee
Number of subjects: 8

Group type: COMPARATOR
Intervention: Coffee with a 3080 kJ meal
Number of subjects: 8
Study: 31710995

Group type: EXPERIMENTAL
Intervention: Total metabolic tumor volume (TMTV) with SUV41max thresholding method
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Total metabolic tumor volume (TMTV) with SUV4 thresholding method
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Interim positron emission tomography (iPET) response with 66% SUVmax reduction
Number of subjects: 510
Study: 31387160

Group type: EXPERIMENTAL
Intervention: Quadrant positioning method
Number of subjects: 72

Group type: COMPARATOR
Intervention: Traditional screw positioning method
Number of subjects: 72
Study: 27530980

Group type: EXPERIMENTAL
Intervention: Mirror-based tactile and motor training
Number of subjects: 6

Group type: COMPARATOR
Intervention: Bimanual therapy (standard practice)
Number of subjects: 6
Study: 25884824

Group type: EXPERIMENTAL
Intervention: Smartphone application (SIMPLe) on top of treatment as usual
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual alone
Number of subjects: 0
Study: 23550962

Group type: EXPERIMENTAL
Intervention: Abusive father-son relationship
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Quantity of alcohol consumption
Number of subjects: 121
Study: 21557114

Group type: EXPERIMENTAL
Intervention: Ketamine (0.24 mg/kg for ED50, 0.33 mg/kg for ED95)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 54
Study: 19724042

Group type: EXPERIMENTAL
Intervention: Bilateral LUNA
Number of subjects: 487

Group type: COMPARATOR
Intervention: Laparoscopy without pelvic denervation (no LUNA)
Number of subjects: 487
Study: 17724363

Group type: EXPERIMENTAL
Intervention: 80 mg i.v. pantoprazole infused for 2 minutes
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 80 mg i.v. pantoprazole infused for 15 minutes
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Visual analogue scale (VAS) for pain and burning
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 48
Study: 15203777

Group type: EXPERIMENTAL
Intervention: 10 US dollars incentive
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: 2 US dollars incentive
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: 0 US dollars incentive
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group (no monetary incentive)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Overall response rate
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Logistic regression analysis
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Median DNA yield
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: PCR amplification potential
Number of subjects: 300
Study: 11157022

Group type: EXPERIMENTAL
Intervention: Intensified treatment (ICE every 2 weeks with filgrastim and autologous blood reinfusion)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard treatment (ICE every 4 weeks)
Number of subjects: 50
Study: 9778080

Group type: EXPERIMENTAL
Intervention: Double-bolus alteplase (two 50 mg bolus injections 30 minutes apart)
Number of subjects: 461

Group type: COMPARATOR
Intervention: Front-loaded alteplase infusion (100 mg total: 15 mg bolus, then 50 mg over 30 minutes, then 35 mg over 60 minutes)
Number of subjects: 461
Study: 8158717

Group type: EXPERIMENTAL
Intervention: Non-acid neutralizing stress ulcer prophylaxis (SUC)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Acid neutralizing prophylaxis (AN)
Number of subjects: 96
Study: 3219313

Group type: EXPERIMENTAL
Intervention: Dietary protein intake at 8.6% of energy
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Dietary protein intake at 11.5% of energy
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Dietary protein intake at 14.0% of energy
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Day 4 of the study period
Number of subjects: 8

Group type: COMPARATOR
Intervention: Overall analysis
Number of subjects: 8
Study: 30191357

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Overall DOAC usage
Number of subjects: 39
Study: 27365387

Group type: EXPERIMENTAL
Intervention: Monoclonal antibodies to C. difficile toxins A and B (not detailed in dosage or duration)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study: 24056586

Group type: EXPERIMENTAL
Intervention: Balanced 6% HES (130/0.4, Volulyte)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Balanced crystalloid (Hartmann's solution)
Number of subjects: 202
Study: 20558112

Group type: EXPERIMENTAL
Intervention: Neuropsychological test battery before antiepileptic treatment
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Neuropsychological test battery after a mean of 5 years
Number of subjects: 50
Study: 18524643

Group type: EXPERIMENTAL
Intervention: Foam sclerosant (3% polidocanol foam, 2-2.5 ml injected)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Liquid sclerosant (3% polidocanol liquid, 2-2.5 ml injected)
Number of subjects: 95
Study: 15965198

Group type: EXPERIMENTAL
Intervention: Donepezil (5-10 mg/day)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 15284372

Group type: EXPERIMENTAL
Intervention: Meal Replacement (MR) group with Slim-Fast products for 2 meals (1800 kJ) and a low-fat evening meal
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control (C) group following a low fat/energy diet with shopping vouchers
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Meal Replacement (MR) group
Number of subjects: 66
Study: 10737167

Group type: COMPARATOR
Intervention: On-line HDF (HDF100)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: On-line HDF (HDF120)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Long-term dialysis patients
Number of subjects: 16
Study: 8649239

Group type: EXPERIMENTAL
Intervention: DHA-supplemented formula (0.2% docosahexaenoic acid)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard formula (control group)
Number of subjects: 0
Study: 1532615

Group type: EXPERIMENTAL
Intervention: Clarithromycin 500 mg twice daily
Number of subjects: 103

Group type: COMPARATOR
Intervention: Ampicillin 500 mg four times daily
Number of subjects: 103
Study: 3924399

Group type: EXPERIMENTAL
Intervention: Sodium-hydrogen divalproate (SHD) 250 mg
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sodium valproate 300 mg
Number of subjects: 14
Study: 3069551

Group type: EXPERIMENTAL
Intervention: ranitidine 300 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: cimetidine 800 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study: 31729491

Group type: EXPERIMENTAL
Intervention: Patients addicted to tobacco (group 1)
Number of subjects: 815

Group type: COMPARATOR
Intervention: Patients who had never smoked (group 2)
Number of subjects: 815
Study: 28266260

Group type: EXPERIMENTAL
Intervention: Psychoeducational group interventions for children with parents suffering from cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychoeducational group interventions for cancer patients and their partners
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting group (control)
Number of subjects: 0
Study: 24448652

Group type: EXPERIMENTAL
Intervention: Omeprazole/sodium bicarbonate (Zegerid(®)) 40 mg once daily for 8 weeks (nighttime dosing)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Omeprazole/sodium bicarbonate (Zegerid(®)) 40 mg once daily for 8 weeks (morning dosing)
Number of subjects: 92
Study: 24070990

Group type: EXPERIMENTAL
Intervention: Music therapy (group songwriting intervention)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Education (group-based condition)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 83
Study: 21150583

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical muscle stimulation applied for 60 mins per day for 7 days.
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control thigh (non-stimulated muscle).
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Comparison of stimulated vs non-stimulated thigh.
Number of subjects: 8
Study: 19095028

Group type: EXPERIMENTAL
Intervention: Inactivated influenza vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Live-attenuated influenza vaccine
Number of subjects: 0
Study: 16501533

Group type: EXPERIMENTAL
Intervention: 25% metronidazole gel
Number of subjects: 302

Group type: COMPARATOR
Intervention: Placebo (KY Jelly)
Number of subjects: 302
Study: 12387171

Group type: EXPERIMENTAL
Intervention: Premixed nitrous oxide and oxygen
Number of subjects: 80
Study: 10189007

Group type: EXPERIMENTAL
Intervention: Propafenone 450‐600 mg orally (PNF)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Propafenone 450‐600 mg orally plus digitalis 0.750‐1 mg i.v. (PNF+D)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Digitalis 0.75‐1 mg i.v. plus quinidine 1100 mg (D+Q)
Number of subjects: 246

Group type: COMPARATOR
Intervention: Placebo (Pl)
Number of subjects: 246
Study: 7499668

Group type: EXPERIMENTAL
Intervention: PSR examination
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional periodontal examination
Number of subjects: 24
Study: 2316591

Group type: EXPERIMENTAL
Intervention: Amoxicillin treatment for 1 day
Number of subjects: 6803

Group type: EXPERIMENTAL
Intervention: Amoxicillin treatment for 3 days
Number of subjects: 6803

Group type: EXPERIMENTAL
Intervention: Amoxicillin treatment for 10 days
Number of subjects: 6803

Group type: EXPERIMENTAL
Intervention: Cephalexin or nitrofurantoin therapy for 7 days (for amoxicillin-resistant infections)
Number of subjects: 6803

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 6803
Study: 453495

Group type: EXPERIMENTAL
Intervention: Methohexitone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Etomidate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methohexitone with fentanyl
Number of subjects: 0

Group type: COMPARATOR
Intervention: Etomidate with fentanyl
Number of subjects: 0
Study: 31982170

Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanate 625mg orally three times a day for a week (treated group)
Number of subjects: 50

Group type: COMPARATOR
Intervention: No antibiotics (untreated group)
Number of subjects: 50
Study: 29081332

Group type: EXPERIMENTAL
Intervention: Self-help manual with treatment rationale
Number of subjects: 69

Group type: COMPARATOR
Intervention: Self-help manual with cognition rationale
Number of subjects: 69
Study: 25345553

Group type: EXPERIMENTAL
Intervention: Power training
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (community-dwelling older adults)
Number of subjects: 75
Study: 25393311

Group type: EXPERIMENTAL
Intervention: Primary Care (PC)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Specialized Care (SC)
Number of subjects: 221
Study: 24051496

Group type: EXPERIMENTAL
Intervention: Endoscopic mucosal resection (EMR)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control group (no EMR)
Number of subjects: 128
Study: 20958183

Group type: EXPERIMENTAL
Intervention: 1% voriconazole (VZ) single dose
Number of subjects: 119

Group type: COMPARATOR
Intervention: 0.1% voriconazole (VZ) single dose
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: 1% voriconazole (VZ) multidose (hourly)
Number of subjects: 119

Group type: COMPARATOR
Intervention: 1% voriconazole (VZ) multidose (bi-hourly)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Reconstituted voriconazole formulations
Number of subjects: 119
Study: 18228109

Group type: EXPERIMENTAL
Intervention: Chlorthalidone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cost-effectiveness analysis
Number of subjects: 0
Study: 17014446

Group type: EXPERIMENTAL
Intervention: On-pump coronary artery bypass grafting (38 patients)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Off-pump coronary artery bypass grafting (14 patients)
Number of subjects: 52
Study: 14613287

Group type: EXPERIMENTAL
Intervention: Risedronate
Number of subjects: 306

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 306
Study: 10391572

Group type: EXPERIMENTAL
Intervention: Intravenous ceftazidime
Number of subjects: 41

Group type: COMPARATOR
Intervention: Oral ciprofloxacin
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 41
Study: 8694152

Group type: EXPERIMENTAL
Intervention: Patient-controlled alfentanil infusion
Number of subjects: 20

Group type: COMPARATOR
Intervention: Patient-controlled bolus administration of morphine
Number of subjects: 20
Study: 1878233

Group type: EXPERIMENTAL
Intervention: 1 mg/kg of famotidine and 0.5 mg/kg of diazepam rectally 30 to 120 minutes before anesthesia induction (Group 2)
Number of subjects: 80

Group type: COMPARATOR
Intervention: 0.5 mg/kg of diazepam rectally 30 to 120 minutes before anesthesia induction (Group 1)
Number of subjects: 80
Study: 7060034

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide, doxorubicin (Adriamycin), and prednisone (CAP)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Carmustine (BCNU), doxorubicin, and prednisone (BAP)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Objective responders (both groups)
Number of subjects: 65
Study: 30715732

Group type: EXPERIMENTAL
Intervention: ProTaper Universal Retreatment system followed by XP‐Endo Finisher file
Number of subjects: 30

Group type: COMPARATOR
Intervention: ProTaper Universal Retreatment system
Number of subjects: 30
Study: 30085138

Group type: EXPERIMENTAL
Intervention: PGT‐A by comprehensive chromosome screening (CCS) of the first and second polar body
Number of subjects: 396

Group type: COMPARATOR
Intervention: ICSI without chromosome screening
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: PGT‐A by CCS
Number of subjects: 396
Study: 27538799

Group type: EXPERIMENTAL
Intervention: Monopolar TURP (M-TURP)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Bipolar TURP (B-TURP)
Number of subjects: 81
Study: 24893225

Group type: EXPERIMENTAL
Intervention: Strategies designed to improve snacks served and increase moderate-to-vigorous physical activity (MVPA) in children attending ASPs.
Number of subjects: 1800
Study: 23121439

Group type: EXPERIMENTAL
Intervention: Platelet-function monitoring with drug adjustment in patients with poor response to antiplatelet therapy.
Number of subjects: 2440

Group type: COMPARATOR
Intervention: Conventional strategy without monitoring and drug adjustment.
Number of subjects: 2440

Group type: EXPERIMENTAL
Intervention: Both groups (monitoring and conventional treatment).
Number of subjects: 2440
Study: 19758398

Group type: EXPERIMENTAL
Intervention: Ondansetron 0.2 mg/kg
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study: 18547842

Group type: EXPERIMENTAL
Intervention: Fluid transport model
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Glucose penetration model
Number of subjects: 80
Study: 15839595

Group type: EXPERIMENTAL
Intervention: Surgical microscope (test group)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional techniques (control group)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study: 12894046

Group type: EXPERIMENTAL
Intervention: Phenoxymethyl penicillin V plus antioxidant vitamins for eight weeks
Number of subjects: 606

Group type: COMPARATOR
Intervention: Phenoxymethyl penicillin V
Number of subjects: 606
Study: 10589108

Group type: EXPERIMENTAL
Intervention: Quick Relaxation Technique (QRT) in conjunction with analgesics
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Quick Relaxation Technique (QRT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Analgesics without relaxation exercises
Number of subjects: 24
Study: 9003882

Group type: EXPERIMENTAL
Intervention: Glucose energy supplementation
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Vitamin supplementation
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 106
Study: 1290186

Group type: EXPERIMENTAL
Intervention: Amrinone
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Enoximone
Number of subjects: 19
Study: 6506368

Group type: EXPERIMENTAL
Intervention: emepronium bromide (Cetiprin) 200 mg 4 times a day
Number of subjects: 75

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 75
Study: 31015165

Group type: EXPERIMENTAL
Intervention: SRT (5 × 5 Gy surgery within one week)
Number of subjects: 840

Group type: EXPERIMENTAL
Intervention: SRT-delay (5 × 5 Gy with surgery after 4–8 weeks)
Number of subjects: 840

Group type: EXPERIMENTAL
Intervention: LRT-delay (2 Gy × 25 with surgery after 4–8 weeks)
Number of subjects: 840

Group type: COMPARATOR
Intervention: pCR vs no-pCR
Number of subjects: 840
Study: 30532289

Group type: EXPERIMENTAL
Intervention: Inactivated BRSV vaccine
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Modified-live (MLV) BRSV vaccine
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (MLV only)
Number of subjects: 18
Study: 28569933

Group type: EXPERIMENTAL
Intervention: Calculation Medicines - CalcMed application, n=50
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional method of calculator use and pre-math skills, n=50
Number of subjects: 100
Study: 24495406

Group type: EXPERIMENTAL
Intervention: Trazodone 50 mg once daily at 10:00 P.M. for 2 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: COMPARATOR
Intervention: Trazodone and Placebo
Number of subjects: 30
Study: 20368384

Group type: EXPERIMENTAL
Intervention: Progressive 24-wk exercise intervention
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41
Study: 18936569

Group type: EXPERIMENTAL
Intervention: Corticosteroid withdrawal (CSWD)
Number of subjects: 386

Group type: COMPARATOR
Intervention: Chronic low dose corticosteroid therapy (CCS)
Number of subjects: 386
Study: 16101168

Group type: EXPERIMENTAL
Intervention: Epoetin alfa 40,000 IU subcutaneously once weekly plus oral iron 200 mg elemental iron once daily
Number of subjects: 100

Group type: COMPARATOR
Intervention: Oral iron 200 mg elemental iron once daily
Number of subjects: 100
Study: 11843741

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 41

Group type: COMPARATOR
Intervention: Propofol (Control)
Number of subjects: 41
Study: 10510925

Group type: EXPERIMENTAL
Intervention: finasteride 5 mg
Number of subjects: 3040

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 3040
Study: 8184044

Group type: EXPERIMENTAL
Intervention: Low-dose thin-section CT (80-mAs)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Conventional-dose thin-section CT (340-mAs)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Chest radiography
Number of subjects: 50
Study: 3213066

Group type: EXPERIMENTAL
Intervention: Ferrum in combination with folic acid
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study: 31955155

Group type: EXPERIMENTAL
Intervention: Active dTMS treatment at 120% resting motor threshold with 18 Hz over the left dorsolateral prefrontal cortex, 1,980 pulses a day, 5 days a week, for 4-6 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham dTMS treatment
Number of subjects: 40
Study: 30501868

Group type: EXPERIMENTAL
Intervention: Dose-adjusted EPOCH-R (DA-EPOCH-R) administered for six cycles with CNS prophylaxis
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Toxicity profile of DA-EPOCH-R
Number of subjects: 53
Study: 28775182

Group type: EXPERIMENTAL
Intervention: Non-mydriatic ultra-wide field (NM UWF) imaging on the day of their clinic visit
Number of subjects: 740

Group type: COMPARATOR
Intervention: Usual screening (encouraged to arrange an exam by an optometrist)
Number of subjects: 740
Study: 24407549

Group type: EXPERIMENTAL
Intervention: Rubber interdental bristle (Fuchs®)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Metal-core interdental brush (TePe®)
Number of subjects: 39
Study: 22170628

Group type: EXPERIMENTAL
Intervention: Hypofractionated stereotactic body radiotherapy (CyberKnife) - 7.5 Gy in 5 fractions
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Hypofractionated stereotactic body radiotherapy (CyberKnife) - 7.25 Gy in 5 fractions
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Hypofractionated stereotactic body radiotherapy (CyberKnife) - other regimens
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Hypofractionated stereotactic body radiotherapy (CyberKnife)
Number of subjects: 45
Study: 20588098

Group type: EXPERIMENTAL
Intervention: Habituation exercises
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Gaze stability (GS) adaptation exercises
Number of subjects: 7